BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,055 filers reported holding BAXTER INTL INC in Q2 2022. The put-call ratio across all filers is 1.57 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $20,795 | -20.6% | 551 | -4.2% | 0.00% | -50.0% |
| Q2 2023 | $26,197 | +18.1% | 575 | +5.1% | 0.00% | 0.0% |
| Q1 2023 | $22,186 | -20.4% | 547 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $27,881 | -45.3% | 547 | -42.2% | 0.00% | -50.0% |
| Q3 2022 | $51,000 | +45.7% | 947 | +73.1% | 0.00% | +33.3% |
| Q2 2022 | $35,000 | -31.4% | 547 | -17.4% | 0.00% | 0.0% |
| Q1 2022 | $51,000 | -10.5% | 662 | 0.0% | 0.00% | -25.0% |
| Q4 2021 | $57,000 | +7.5% | 662 | 0.0% | 0.00% | +33.3% |
| Q3 2021 | $53,000 | 0.0% | 662 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $53,000 | -5.4% | 662 | 0.0% | 0.00% | -25.0% |
| Q1 2021 | $56,000 | -3.4% | 662 | -8.8% | 0.00% | 0.0% |
| Q4 2020 | $58,000 | 0.0% | 726 | 0.0% | 0.00% | -20.0% |
| Q3 2020 | $58,000 | +9.4% | 726 | +18.8% | 0.01% | 0.0% |
| Q2 2020 | $53,000 | +6.0% | 611 | 0.0% | 0.01% | 0.0% |
| Q1 2020 | $50,000 | +8.7% | 611 | +11.7% | 0.01% | +25.0% |
| Q4 2019 | $46,000 | -41.0% | 547 | -38.7% | 0.00% | -42.9% |
| Q3 2019 | $78,000 | +1.3% | 892 | -4.7% | 0.01% | 0.0% |
| Q2 2019 | $77,000 | +75.0% | 936 | +71.1% | 0.01% | +75.0% |
| Q1 2019 | $44,000 | +22.2% | 547 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $36,000 | -36.8% | 547 | -25.4% | 0.00% | -33.3% |
| Q3 2018 | $57,000 | -32.1% | 733 | -35.3% | 0.01% | -33.3% |
| Q2 2018 | $84,000 | +13.5% | 1,133 | 0.0% | 0.01% | +12.5% |
| Q1 2018 | $74,000 | -25.3% | 1,133 | -26.1% | 0.01% | -20.0% |
| Q4 2017 | $99,000 | +3.1% | 1,533 | 0.0% | 0.01% | 0.0% |
| Q3 2017 | $96,000 | +17.1% | 1,533 | +13.8% | 0.01% | +11.1% |
| Q2 2017 | $82,000 | +17.1% | 1,347 | 0.0% | 0.01% | +12.5% |
| Q1 2017 | $70,000 | +16.7% | 1,347 | 0.0% | 0.01% | +14.3% |
| Q4 2016 | $60,000 | -6.2% | 1,347 | 0.0% | 0.01% | 0.0% |
| Q3 2016 | $64,000 | +4.9% | 1,347 | 0.0% | 0.01% | 0.0% |
| Q2 2016 | $61,000 | +10.9% | 1,347 | 0.0% | 0.01% | +16.7% |
| Q1 2016 | $55,000 | +7.8% | 1,347 | 0.0% | 0.01% | 0.0% |
| Q4 2015 | $51,000 | +15.9% | 1,347 | 0.0% | 0.01% | +20.0% |
| Q3 2015 | $44,000 | -57.3% | 1,347 | -8.9% | 0.01% | -58.3% |
| Q2 2015 | $103,000 | -3.7% | 1,478 | -5.4% | 0.01% | 0.0% |
| Q1 2015 | $107,000 | -8.5% | 1,562 | -2.5% | 0.01% | 0.0% |
| Q4 2014 | $117,000 | +1.7% | 1,602 | 0.0% | 0.01% | 0.0% |
| Q3 2014 | $115,000 | +15.0% | 1,602 | +15.5% | 0.01% | +9.1% |
| Q2 2014 | $100,000 | -4.8% | 1,387 | -2.8% | 0.01% | -8.3% |
| Q1 2014 | $105,000 | +6.1% | 1,427 | 0.0% | 0.01% | +9.1% |
| Q4 2013 | $99,000 | +5.3% | 1,427 | 0.0% | 0.01% | 0.0% |
| Q3 2013 | $94,000 | -5.1% | 1,427 | 0.0% | 0.01% | -15.4% |
| Q2 2013 | $99,000 | – | 1,427 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |